BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Enanta Pharmaceuticals Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

  October 3, 2025

   · 

  4 min read
• Press Releases

  Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 2, 2025

  October 3, 2025

   · 

  2 min read
• Press Releases

  XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.

  October 3, 2025

   · 

  10 min read
• Press Releases

  Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 2, 2025

  October 3, 2025

   · 

  1 min read
• Press Releases

  Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 2, 2025

  October 3, 2025

   · 

  2 min read
• Press Releases

  Encora Therapeutics Names Nadim Yared as Chairman and Chief Executive Officer

  October 3, 2025

   · 

  2 min read
• Press Releases

  Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 2, 2025

  October 3, 2025

   · 

  1 min read
• Press Releases

  Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - October 2, 2025

  October 3, 2025

   · 

  2 min read
• Press Releases

  FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

  October 3, 2025

   · 

  11 min read
• Press Releases

  Ryoncil® Receives J-Code From Medicare & Medicaid Services (CMS) Facilitating Reimbursement and Broader Patient Access

  October 3, 2025

   · 

  6 min read